PhytoTech, LLC is a New York-based biotech-company developing novel antiviral treatments to treat viral infections, particularly targeting members of the Flaviviridae virus family, including flaviviruses, pestiviruses (including BVDV), and hepaciviruses. The company is currently focusing on developing novel therapies specifically tailored for the treatment of cancers and other deadly diseases caused by viral infections. The company was founded based on intellectual property generated from Cornell University.
